Patrice Milos, PhD, has been appointed as the new board chair for RI Bio. Dr. Milos is the president/CEO and co-founder of Medley Genomics, a life sciences company dedicated to addressing the challenges of genomic heterogeneity in the diagnosis and treatment of complex diseases. Initially focused in oncology, Medley provides unique ‘molecular fingerprints’ of a patient’s cancer enabling individualized diagnosis and optimal treatment.
“Patrice is a pioneer at the interface of genomics and medicine and brings her highly innovative industry expertise and strong leadership skills to the board,” said Carol Malysz, executive director, RI Bio. “Her board leadership will help RI Bio to grow to new levels of distinction and impact in the RI life sciences community.”
Dr. Milos has served as a member of the RI Bio board since October 2017.